Evidence map›Paper›PMID 40901013›Full record

ReviewFrontiers in surgery2025

Pipkin type III fractures: a narrative review of literature and comparative opinion on ORIF vs. arthroplasty.

Sujan Shakya, Qing Zhang, Yi Wen, Xinag Wen, Long Cheng

Abstract readReview
In one paragraph

Review in Frontiers in surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sujan ShakyaWest China School of Medicine, West China Hospital, Sichuan University, Chengdu, China.
Qing ZhangWest China School of Medicine, West China Hospital, Sichuan University, Chengdu, China.
Yi WenWest China School of Medicine, West China Hospital, Sichuan University, Chengdu, China.
Xinag WenWest China School of Medicine, West China Hospital, Sichuan University, Chengdu, China.
Long ChengWest China School of Medicine, West China Hospital, Sichuan University, Chengdu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pipkin Type III is extremely rare and is associated with worse prognosis and several complications. There is still no consensus on the management of injuries and whether these fractures should be treated surgically with ORIF or arthroplasty. Pipkin type III involves a combination of ipsilateral femoral head and neck fractures. Physioanatomical complexity of this fracture is often challenging, with a poorer prognosis than any other subgroups. The most common complications after management of Pipkin Type III are avascular necrosis of the femoral head and post-traumatic osteoarthritis. The treatment modality with open reduction and internal fixation (ORIF) or total hip arthroplasty (THA) varies according to the severity of the fracture, patient age, time to surgery, and intraoperative findings. Reoperation and surgical intervention pose significant economic burden, functional impairment, and quality of life. This comprehensive review on Pipkin type III demonstrates a throughout exploration of the existing research publications and case studies, focusing on current understanding treatment management strategies, outcome associated and decision-making frameworks with algorithms for decision schemes. By incorporating additional references of our institutional experiences, it aims to expand the current body of knowledge on Pipkin III fractures, offering fresh perspectives and crucial insights for surgeons in decision-making processes.

Indexed as

avascular necrosisfemoral head fractureORIFPipkin III fractureTHA

Identifiers

PMID40901013
PMCPMC12399708

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.